Spondyloarthropathies: Targeted therapy for psoriatic arthritis.
Tumor necrosis factor inhibitors are an effective treatment for psoriatic arthritis, but no single agent is effective in all patients. Novel therapies that target other cytokines have now been tested, with encouraging results.